Weekly Digest – August 2025 Weekly Digest – August 2025 12 August 2025: PADCEV™ Plus KEYTRUDA™ Significantly Improves Survival for Certain Patients with Bladder Cancer When Given Before and After Surgery PADCEV plus KEYTRUDA is the first regimen to significantly […]
Contact:
info@ciscientists.com
+1-908-212-7484
Optimal Dose
For a subscription, please provide your email id